Skip to NavigationSkip to content

Pharmafile.com's weekly COVID-19 news round-up

Published on 23/09/20 at 09:34am

The coronavirus news this week largely focuses on clinical trial results, with Pfizer saying that participants in a late-stage trial for its COVID-19 vaccine candidate have shown mild to moderate side effects, while Roche says that its Actermra/Roactemra drugs reduce the likelihood that coronavirus patients with virus-related pneumonia will need to be put on a ventilator.

In other news, a new study that alleges COVID-19 was created in a Chinese lab was published by two non-profits that are linked to President Trump’s former chief strategist Steve Bannon.

1.Pfizer’s coronavirus vaccine shows moderate side-effects in clinical studyPublished 16/09/20

Pfizer has said that participants in a late-stage trial for its COVID-19 vaccine candidate have shown mild to moderate side effects.

2. Study that alleges COVID-19 was made in a Chinese lab originated from non-profits linked to ex-Trump advisor Steve BannonPublished 16/09/20

A new study that alleges COVID-19 was created in a Chinese lab was published by two non-profits that are linked to President Trump’s former chief strategist Steve Bannon, it has emerged.

3. India signs deal for 100m doses of Russia's Sputnik V COVID-19 vaccinePublished 16/09/20

Russia has signed a deal with an Indian pharma firm to test and deliver 100 million doses of its controversial Sputnik V vaccine for COVID-19 to the nation’s citizens as it sees its death toll surge to overtake Brazil as the second-worst hit country on Earth after the US.

4. Oxford University says participant illness that halted its COVID-19 trial may not be linked to the vaccinePublished 17/09/20

The illness of one of the participants in the Oxford-AstraZeneca COVID-19 vaccine trial may not have been caused by the treatment itself, according to newly revealed information.

5. Roche says its rheumatoid arthritis drug reduces the need for ventilators in coronavirus patientsPublished 18/09/20

Roche says that its Actermra/Roactemra drugs reduce the likelihood that coronavirus patients with virus-related pneumonia will need to be put on a ventilator.

Conor Kavanagh

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches